Drug Guide
Pemirolast Potassium
Classification
Therapeutic: Antiallergic agent
Pharmacological: mast cell stabilizer
FDA Approved Indications
- Allergic conjunctivitis
Mechanism of Action
Pemirolast stabilizes mast cell membranes, preventing the release of inflammatory mediators like histamine, thereby reducing allergic responses.
Dosage and Administration
Adult: One drop in each affected eye 4 times daily
Pediatric: Same as adults; safety and efficacy established for children aged 3 years and older
Geriatric: No specific dosage adjustment required; use with caution as with other medications
Renal Impairment: No specific dose adjustment required but monitor for efficacy and tolerability
Hepatic Impairment: No specific dose adjustment available
Pharmacokinetics
Absorption: Minimal systemic absorption from ocular administration
Distribution: Primarily localized to ocular tissues
Metabolism: Not extensively metabolized systemically
Excretion: Primarily via ocular tissues; systemic excretion details limited
Half Life: Data not well established, likely short due to topical use
Contraindications
- Hypersensitivity to pemirolast or any component of the formulation
Precautions
- Use cautiously in patients with active ocular infections or injuries; inform patients about potential allergenic reactions.
Adverse Reactions - Common
- Ocular discomfort, burning, or stinging (Common)
- Blurred vision (Uncommon)
Adverse Reactions - Serious
- Eye pain, swelling, or tearing (Rare)
- Anaphylaxis (extremely rare) (Very rare)
Drug-Drug Interactions
N/ADrug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Assess ocular condition before and during treatment for effectiveness and adverse reactions.
Diagnoses:
- Risk for injury related to adverse ocular reactions
Implementation: Administer as prescribed; instruct on proper eye drop technique.
Evaluation: Monitor symptom relief and detect any adverse effects.
Patient/Family Teaching
- Use medication exactly as prescribed.
- Avoid touching the dropper tip to eyes or other surfaces.
- Report any signs of adverse reactions such as persistent eye pain, swelling, or vision changes.
- Notify healthcare provider if symptoms worsen or do not improve within the expected time frame.
Special Considerations
Black Box Warnings: N/A
Genetic Factors: None known
Lab Test Interference: No significant interference reported in laboratory tests.
Overdose Management
Signs/Symptoms: Ocular irritation, redness, or systemic allergic reactions (rare).
Treatment: Wash the eyes with water; seek medical attention if symptoms are severe or persist.
Storage and Handling
Storage: Store at room temperature, away from moisture and light.
Stability: Stable when stored properly; check expiration date regularly.